Ernexa Therapeutics, Inc.

Eterna Therapeutics Inc. is a biopharmaceutical company dedicated to revolutionizing cell and gene therapies through innovative biotechnology solutions. The company's primary function is to develop groundbreaking treatments targeting rare and complex diseases by utilizing advanced genomic editing and delivery systems. Eterna Therapeutics focuses on leveraging its proprietary technology across various fields, including oncology, regenerative medicine, and genetic disorders. With a mission to address significant unmet medical needs, the company is at the forefront of creating therapies that are designed to be safer and more effective. Eterna Therapeutics' ongoing research and development activities position it as a pivotal player in the rapidly evolving biopharmaceutical landscape. Through strategic partnerships and a commitment to scientific excellence, the company aims to transform how the medical community approaches the treatment of challenging health conditions, providing new pathways to health and wellness for patients worldwide.